- Home
- SPRY vs DAVA Comparison
SPRY vs DAVA Comparison
Compare SPRY & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- DAVA
- Stock Information
- Founded
- SPRY 2015
- DAVA 2000
- Country
- SPRY United States
- DAVA United Kingdom
- Employees
- SPRY N/A
- DAVA N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- SPRY Health Care
- DAVA Technology
- Exchange
- SPRY Nasdaq
- DAVA Nasdaq
- Market Cap
- SPRY 1.2B
- DAVA 1.2B
- IPO Year
- SPRY N/A
- DAVA 2018
- Fundamental
- Price
- SPRY $14.88
- DAVA $17.10
- Analyst Decision
- SPRY Strong Buy
- DAVA Buy
- Analyst Count
- SPRY 4
- DAVA 12
- Target Price
- SPRY $28.75
- DAVA $39.43
- AVG Volume (30 Days)
- SPRY 2.2M
- DAVA 483.1K
- Earning Date
- SPRY 05-08-2025
- DAVA 05-22-2025
- Dividend Yield
- SPRY N/A
- DAVA N/A
- EPS Growth
- SPRY N/A
- DAVA N/A
- EPS
- SPRY 0.08
- DAVA 0.12
- Revenue
- SPRY $89,149,000.00
- DAVA $950,741,765.00
- Revenue This Year
- SPRY $1.49
- DAVA $9.65
- Revenue Next Year
- SPRY $141.68
- DAVA $8.30
- P/E Ratio
- SPRY $186.00
- DAVA $146.48
- Revenue Growth
- SPRY 297063.34
- DAVA N/A
- 52 Week Low
- SPRY $7.55
- DAVA $16.70
- 52 Week High
- SPRY $18.51
- DAVA $34.94
- Technical
- Relative Strength Index (RSI)
- SPRY 66.37
- DAVA 33.99
- Support Level
- SPRY $11.80
- DAVA $17.06
- Resistance Level
- SPRY $15.12
- DAVA $18.50
- Average True Range (ATR)
- SPRY 1.04
- DAVA 1.22
- MACD
- SPRY 0.20
- DAVA 0.14
- Stochastic Oscillator
- SPRY 92.77
- DAVA 12.94
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.